Photo-clenbuterol: Optical Control of β(2)-Adrenergic Receptor Signaling by Photoswitchable Ligand Efficacy.

Clenbuterol is a potent partial agonist on the human β(2)-adrenergic receptor (β(2)-AR) and available for veterinary use to treat respiratory diseases. We executed an "azoextension" strategy to generate a small library of photoresponsive azobenzene derivatives of clenbuterol. Illumination with two complementary wavelengths allowed interconversion between isomeric trans and cis forms, as proven by UV/vis, NMR and LC-MS studies. The photoswitchable clenbuterol analogs were pharmacologically characterized using β(2)-AR radioligand binding and cAMP assays. Key compound 12b (VUF26034) has suitable photochemical properties and good thermal stability of the cis isomer (t(1/2) ∼ 4 months), switching from a partial agonist to a >25-fold higher affinity antagonist upon illumination with 360 nm.